Breast Cancer Clinical Trials in Phoenix, AZ

View the best 10 breast cancer medical studies in Phoenix, Arizona. Access promising new therapies by applying to a Phoenix-based Breast Cancer clinical trial.

Trials in Phoenix, Arizona

Here are the top 10 medical studies for breast cancer in Phoenix, Arizona

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

Proton +1 More

Proton Beam Therapy

Recruiting1 award12 criteria

This trial is testing whether proton therapy or photon therapy is better for treating breast cancer. It will follow patients for side effects, quality of life, and cancer control.

External Beam Radiation Therapy

Recruiting1 award3 criteria

This trial is testing whether eliminating surgery and just using radiation therapy after systemic therapy works well in treating patients with HER2 positive or triple negative breast cancer.

Fulvestrant +2 More

Estrogen Receptor Antagonist

Recruiting1 awardPhase 2

This trial is for people with solid tumors that make too much HER2 or a different type of HER2. Participants will get tucatinib and trastuzumab. People with hormone-receptor positive breast cancer will also get fulvestrant. The trial will look at side effects.

Capecitabine

Anti-metabolites

Recruiting1 awardPhase 2

This trial is testing the use of a drug called capecitabine in patients with a specific type of breast cancer that has spread to other parts of the body. Capecitabine works

Capecitabine +2 More

Antimetabolites

Recruiting2 awardsPhase 3

This trial will test if a new combination of drugs is more effective and safer than standard treatments for triple negative breast cancer.

WBI

Radiation Therapy

Recruiting1 award17 criteria

This trial is comparing two types of radiation therapy to treat early-stage breast cancer.

Stereotactic Body Radiotherapy +2 More

Radiation

Recruiting1 awardPhase 2 & 3

This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.

Anastrozole +5 More

Aromatase Inhibitor

Recruiting3 awardsPhase 4

This trial will assess the long-term safety of ribociclib when used in combination with other drugs in participants who have already benefited from the treatment.

Imlunestrant

Selective Estrogen Receptor Downregulator (SERD)

Recruiting2 awardsPhase 3

This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.

Popular Filters

Phase 3 Trials

Support Program for Breast Cancer

Recruiting2 awardsPhase 3

Santa Maria, California

This trial looks at how well patients stick to their medication plan when given text reminders and/or phone counseling.

Radiation

Surgery or High-Dose Radiation for Metastatic Breast Cancer

Recruiting1 awardPhase 2 & 3

Peoria, Arizona

This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.

N/A

Radiation vs. Radiation + Lymph Node Dissection for Breast Cancer

Recruiting2 awardsPhase 3

Phoenix, Arizona

This trial is comparing radiation therapy alone to radiation therapy with lymph node dissection in treating breast cancer patients who have already had chemotherapy and surgery.

Monoclonal Antibodies

Dato-DXd + Durvalumab for Breast Cancer

Recruiting2 awardsPhase 3

Goodyear, Arizona

This trial tests the effectiveness and safety of new treatments for TNBC and hormone receptor-low/HER2-negative breast cancer.

CDK4/6 Inhibitor

Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib for Breast Cancer

Recruiting2 awardsPhase 3

Scottsdale, Arizona

This trial will explore a new combination of drugs to treat breast cancer in people who have previously received other treatments.

Platinum-based Chemotherapy

Platinum Chemotherapy for Triple-Negative Breast Cancer

Recruiting3 awardsPhase 3

Phoenix, Arizona

This trial is comparing two types of chemotherapy drugs to see which is more effective in treating patients with residual triple negative basal-like breast cancer.

Trials With No Placebo

Targeted Therapy

Targeted Therapy for Solid Tumors

Recruiting1 awardPhase 2

Las Vegas, Nevada

This trial helps cancer patients find treatments tailored to their unique genetic makeup. It could improve their outcomes.

Aromatase Inhibitor

Ribociclib Combination Therapy for Breast Cancer

Recruiting3 awardsPhase 4

Chandler, Arizona

This trial will assess the long-term safety of ribociclib when used in combination with other drugs in participants who have already benefited from the treatment.

Behavioral Intervention

Exercise for Breast Cancer Cognitive Function

Recruiting1 award8 criteria

Scottsdale, Arizona

This trial will test if exercise can improve cognitive function in post-menopause breast cancer survivors.

Support Program for Breast Cancer

Recruiting2 awardsPhase 3

Santa Maria, California

This trial looks at how well patients stick to their medication plan when given text reminders and/or phone counseling.

GSK-3β inhibitor

9-ING-41 for Advanced Cancers

Recruiting1 awardPhase 2

Phoenix, Arizona

This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.

Checkpoint Inhibitor

Nivolumab + Ipilimumab for Rare Cancers

Recruiting1 awardPhase 2

Phoenix, Arizona

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Conditions

Locations

Psychology Related

Treatments

Cities

Breast Cancer Clinical Trials in Phoenix, AZ

Trials in Phoenix, Arizona

Nivolumab +1 More

Checkpoint Inhibitor

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

Proton +1 More

Proton Beam Therapy

This trial is testing whether proton therapy or photon therapy is better for treating breast cancer. It will follow patients for side effects, quality of life, and cancer control.

External Beam Radiation Therapy

This trial is testing whether eliminating surgery and just using radiation therapy after systemic therapy works well in treating patients with HER2 positive or triple negative breast cancer.

Fulvestrant +2 More

Estrogen Receptor Antagonist

This trial is for people with solid tumors that make too much HER2 or a different type of HER2. Participants will get tucatinib and trastuzumab. People with hormone-receptor positive breast cancer will also get fulvestrant. The trial will look at side effects.

Capecitabine

Anti-metabolites

This trial is testing the use of a drug called capecitabine in patients with a specific type of breast cancer that has spread to other parts of the body. Capecitabine works

Capecitabine +2 More

Antimetabolites

This trial will test if a new combination of drugs is more effective and safer than standard treatments for triple negative breast cancer.

WBI

Radiation Therapy

This trial is comparing two types of radiation therapy to treat early-stage breast cancer.

Stereotactic Body Radiotherapy +2 More

Radiation

This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.

Anastrozole +5 More

Aromatase Inhibitor

This trial will assess the long-term safety of ribociclib when used in combination with other drugs in participants who have already benefited from the treatment.

Imlunestrant

Selective Estrogen Receptor Downregulator (SERD)

Popular Filters

Phase 3 Trials

Support Program for Breast Cancer

This trial looks at how well patients stick to their medication plan when given text reminders and/or phone counseling.

Radiation

Surgery or High-Dose Radiation for Metastatic Breast Cancer

This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.

N/A

Radiation vs. Radiation + Lymph Node Dissection for Breast Cancer

This trial is comparing radiation therapy alone to radiation therapy with lymph node dissection in treating breast cancer patients who have already had chemotherapy and surgery.

Monoclonal Antibodies

Dato-DXd + Durvalumab for Breast Cancer

This trial tests the effectiveness and safety of new treatments for TNBC and hormone receptor-low/HER2-negative breast cancer.

CDK4/6 Inhibitor

Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib for Breast Cancer

This trial will explore a new combination of drugs to treat breast cancer in people who have previously received other treatments.

Platinum-based Chemotherapy

Platinum Chemotherapy for Triple-Negative Breast Cancer

This trial is comparing two types of chemotherapy drugs to see which is more effective in treating patients with residual triple negative basal-like breast cancer.

Trials With No Placebo

Targeted Therapy

Targeted Therapy for Solid Tumors

This trial helps cancer patients find treatments tailored to their unique genetic makeup. It could improve their outcomes.

Aromatase Inhibitor

Ribociclib Combination Therapy for Breast Cancer

This trial will assess the long-term safety of ribociclib when used in combination with other drugs in participants who have already benefited from the treatment.

Behavioral Intervention

Exercise for Breast Cancer Cognitive Function

This trial will test if exercise can improve cognitive function in post-menopause breast cancer survivors.

Support Program for Breast Cancer

This trial looks at how well patients stick to their medication plan when given text reminders and/or phone counseling.

GSK-3β inhibitor

9-ING-41 for Advanced Cancers

This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.

Checkpoint Inhibitor

Nivolumab + Ipilimumab for Rare Cancers

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

View More Related Trials

View more breast-cancer clinical trials phoenix

Frequently Asked Questions

Other Trials to Consider

Rhenium Re 188 P2045

Rigosertib Sodium

KITE-363

Abelacimab

Brilaroxazine

R3R01

REM-001

RGX-314

Placebo